A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2011
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011	US8057814 Drug delivery from stents
11/15/2011	US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011	CA2666975C Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
11/15/2011	CA2549995C Ketone compounds and compositions for cholesterol management and related uses
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2368772C Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
11/12/2011	CA2740237A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/10/2011	WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011	WO2011139951A1 Modulators of fatty acid amide hydrolase
11/10/2011	WO2011139391A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/10/2011	WO2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
11/10/2011	WO2011137734A1 Pharmaceutical composition and method for treating hypertension
11/10/2011	WO2011137601A1 Compound pharmaceutical formulation of levoamlodipine
11/10/2011	WO2011082245A3 Metalloenzyme inhibitor compounds
11/10/2011	WO2011081970A3 MOLECULES RELATED hERG Ion CHANNELS AND THE USE THEREOF
11/10/2011	WO2011079273A3 Methods and compositions for cardiovascular diseases and conditions
11/10/2011	WO2011072119A3 Stem-cell material and method of use
11/10/2011	WO2011066201A3 Methods and systems for treating and preventing cardiac injury in dystrophic subjects
11/10/2011	US20110275827 Mitotic Kinesin Inhibitor
11/10/2011	US20110275713 Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275682 Novel choline cocrystal of epalrestat
11/10/2011	US20110275681 Novel solid forms of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011	US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
11/10/2011	US20110275670 New Compounds VII
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275660 Beta carboline sulphonylurea derivatives as ep4 receptor antagonists
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275642 New method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275631 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275620 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275614 Methods for the preparation of ivabradine sulfate and form i crystal thereof
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275594 Oral dosage form
11/10/2011	US20110275587 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275571 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275568 Methods of enhancing functioning of the large intestine
11/10/2011	US20110275565 Biocompatible polysaccharide-based hydrogels
11/10/2011	US20110275563 Use of CTGF as a Cardioprotectant
11/10/2011	US20110275556 Treatment of atherosclerosis
11/10/2011	US20110274772 Ointment for the topical treatment of haemorrhoids
11/10/2011	US20110274751 Trimetazidine formulation with different release profiles
11/10/2011	US20110274746 Therapeutic Liposomes and Methods For Producing and Using the Same
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274734 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274694 ERK1/2 Posphorylation Site Specific Antibody
11/10/2011	US20110274691 Ferroportin antibodies and methods of use
11/10/2011	US20110274680 Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
11/10/2011	US20110274674 Ischemic tissue cell therapy
11/10/2011	US20110274667 Methods for obtaining cell populations from adipose tissue
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385047A1 Piperidinyl-substituted isoquinolone derivatives
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384327A1 Fused ring compound and use thereof
11/09/2011	EP2384198A2 Pharmaceutical compositions and methods of treating neurological insults
11/09/2011	EP2384197A1 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes
11/09/2011	EP2384192A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
11/09/2011	EP2078022B1 Spiro benzazepines used as vasopressin antagonists
11/09/2011	EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011	EP1796480B1 Fermented milk proteins comprising receptor ligand and uses thereof
11/09/2011	EP1693451B1 Method of growing myocardial cells
11/09/2011	EP1669450B1 Staple type oligonucleotide and drug comprising the same
11/09/2011	EP1526862B1 Simmondsin for use as an angiogenesis inhibitor
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	CN1931232B Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1595